The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

L. B. Ramsey, S. G. Johnson, K. E. Caudle, C. E. Haidar, D. Voora, R. A. Wilke, W. D. Maxwell, L. McLeod, R. M. Krauss, D. M. Roden, Q. Feng, R. M. Cooper-DeHoff, L. Gong, T. E. Klein, M. Wadelius, Mikko Niemi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume96
Issue number4
Pages (from-to)423-428
Number of pages6
ISSN0009-9236
DOIs
Publication statusPublished - Oct 2014
MoE publication typeA1 Journal article-refereed

Fields of Science

  • STATIN-INDUCED MYOPATHY
  • HIGH-RISK INDIVIDUALS
  • OATP-C
  • CONTROLLED-TRIAL
  • GENETIC VARIANT
  • PHARMACOKINETICS
  • ROSUVASTATIN
  • DRUG
  • POLYMORPHISMS
  • SLCO1B1-ASTERISK-5
  • 3111 Biomedicine

Cite this